Cushman & Wakefield plc

NYSE:CWK

10.25 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 2,284.62,629.52,344.22,2882,184.82,552.42,2862,4062,249.32,6472,515.12,612.62,3312,883.72,332.92,248.31,923.82,273.11,931.61,743.61,895.42,607.52,118.82,121.71,9032,401.92,0761,974.31,767.72,052.71,709.31,700.61,461.3
Cost of Revenue 1,900.32,101.11,911.81,9061,832.52,073.81,882.11,978.11,907.62,162.62,052.92,077.51,860.52,226.31,850.21,782.41,589.51,8031,599.61,453.91,598.82,037.61,692.21,687.11,564.81,915.41,687.21,564.71,473.31,6021,421.31,379.71,236.6
Gross Profit 384.3528.4432.4382352.3478.6403.9427.9341.7484.4462.2535.1470.5657.4482.7465.9334.3470.1332289.7296.6569.9426.6434.6338.2486.5388.8409.6294.4450.7288320.9224.7
Gross Profit Ratio 0.1680.2010.1840.1670.1610.1880.1770.1780.1520.1830.1840.2050.2020.2280.2070.2070.1740.2070.1720.1660.1560.2190.2010.2050.1780.2030.1870.2070.1670.220.1680.1890.154
Reseach & Development Expenses 000000000000000000000000000000000
General & Administrative Expenses 305.8319.7314.2294.2296317.1300.9328.9315.9650.4315.6317.5293.4359.2302.5284.2280.8310.4254.3272.1284364.5315.2306.9286.8365.3307.4311.9294.9316.6276281281.8
Selling & Marketing Expenses 0000039.900041.8000000035.400049.800052.700054.7000
SG&A 305.8319.7314.2294.2296317.1300.9328.9315.9650.4315.6317.5293.4359.2302.5284.2280.8310.4254.3272.1284364.5315.2306.9286.8365.3307.4311.9294.9316.6276281281.8
Other Expenses 00433.31.70.2-2-4.836.9-282.933.939.740.6-14.63.710.1210.5-8.639.10.30.42.20.60.8-0.3219.80.90.20.1
Operating Expenses 305.8319.7357.2325.4328.5353.9337.1364.6352.8367.5349.5357.2334403345.2326.7323.9362.5319.2346.7356438.4390.2381.2360.3442.3379383.5364.7394.2340.1346.9344.8
Operating Income 45.3174.575.288.918.811057.656.3-5.2111.1112.1176.6135.3249.4130.3124.5-7.295.5-0.3-62.8-85.5123.13753.2-2643.21132.5-80.740.7-54.6-36.1-120.2
Operating Income Ratio 0.020.0660.0320.0390.0090.0430.0250.023-0.0020.0420.0450.0680.0580.0860.0560.055-0.0040.042-0-0.036-0.0450.0470.0170.025-0.0140.0180.0050.016-0.0460.02-0.032-0.021-0.082
Total Other Income Expenses Net -40.3-42.4-22.2-53.2-45.3-39.9-74.9-49.9-70.9-22.3-62-53.6-59.2-51.8-38.7-28.6-38-40.1-41.6-45.73.9-36.9-36.3-35.5-35.8-38.2-92.6-49.6-43-38-47.8-43.7-41.2
Income Before Tax 5132.15317.2-26.570.1-17.36.4-89.288.850.112376.1197.691.695.9-45.255.4-41.9-108.5-81.686.20.717.7-61.85-81.6-17.1-123.72.7-102.4-79.8-161.4
Income Before Tax Ratio 0.0020.050.0230.008-0.0120.027-0.0080.003-0.040.0340.020.0470.0330.0690.0390.043-0.0230.024-0.022-0.062-0.0430.03300.008-0.0320.002-0.039-0.009-0.070.001-0.06-0.047-0.11
Income Tax Expense 3.119.219.33.72.30.316.61.3-12.85926.225.830.651.822.943.2-2882.7-4.6-7.7-26.583.1-1111.4-40.923-32.915.1-31.7-22.4-23.8-32.5-41.7
Net Income 1.9112.933.713.5-28.869.8-33.95.1-76.429.823.997.245.5145.868.752.7-17.2-27.3-37.3-100.8-55.13.111.76.3-20.9-18-48.7-32.2-9225.1-78.6-47.3-119.7
Net Income Ratio 0.0010.0430.0140.006-0.0130.027-0.0150.002-0.0340.0110.010.0370.020.0510.0290.023-0.009-0.012-0.019-0.058-0.0290.0010.0060.003-0.011-0.007-0.023-0.016-0.0520.012-0.046-0.028-0.082
EPS 0.010.490.150.059-0.130.31-0.150.023-0.340.130.110.430.20.650.310.24-0.08-0.12-0.17-0.46-0.250.010.050.03-0.097-0.089-0.27-0.15-0.510.14-0.43-0.26-0.66
EPS Diluted 0.010.480.140.058-0.130.3-0.150.023-0.340.130.110.430.20.640.30.23-0.077-0.12-0.17-0.46-0.250.010.050.03-0.097-0.086-0.26-0.15-0.510.14-0.43-0.26-0.66
EBITDA 79.2253118.211956.8160.21039925.8148.3157.6217.6176.6298.1179.8181.454.2192.978.345.640.4205.4111.7127.779.2121.793.795.9-1.3143.917.539.9-57.1
EBITDA Ratio 0.0350.0960.050.0520.0260.0630.0450.0410.0110.0560.0630.0830.0760.1030.0770.0810.0280.0850.0410.0260.0210.0790.0530.060.0420.0510.0450.049-0.0010.070.010.023-0.039